,ONTOLOGY,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0048511,BP,GO:0048511,rhythmic process,10/42,305/18866,9.80351712284646e-10,1.47346862356382e-06,9.5145713550152e-07,ADAMTS1/BHLHE40/CLDN4/EGR1/EGR2/EGR3/JUN/JUND/PER2/SIK1,10
GO:0007623,BP,GO:0007623,circadian rhythm,8/42,218/18866,2.35354941385092e-08,1.76869238450896e-05,1.1420908208266e-05,BHLHE40/CLDN4/EGR1/EGR3/JUN/JUND/PER2/SIK1,8
GO:0035914,BP,GO:0035914,skeletal muscle cell differentiation,5/42,69/18866,4.32522391771353e-07,0.000140432236670982,9.06807593309141e-05,ATF3/BTG2/EGR1/EGR2/FOS,5
GO:0009314,BP,GO:0009314,response to radiation,9/42,447/18866,4.8371484315174e-07,0.000140432236670982,9.06807593309141e-05,BHLHE40/DUSP1/EGR1/FOS/JUND/PER2/PLK3/RHOB/SIK1,9
GO:0043434,BP,GO:0043434,response to peptide hormone,9/42,447/18866,4.8371484315174e-07,0.000140432236670982,9.06807593309141e-05,BTG2/EGR1/EGR2/JUND/NR4A1/NR4A2/NR4A3/PTPN2/SOCS3,9
GO:0006979,BP,GO:0006979,response to oxidative stress,9/42,458/18866,5.9268870230666e-07,0.000140432236670982,9.06807593309141e-05,DUSP1/FOS/JUN/KLF2/MCL1/NR4A2/NR4A3/PLK3/RHOB,9
GO:0000302,BP,GO:0000302,response to reactive oxygen species,7/42,235/18866,7.92025590785174e-07,0.000140432236670982,9.06807593309141e-05,DUSP1/FOS/JUN/KLF2/NR4A3/PLK3/RHOB,7
GO:0045444,BP,GO:0045444,fat cell differentiation,7/42,235/18866,7.92025590785174e-07,0.000140432236670982,9.06807593309141e-05,EGR2/NR4A1/NR4A2/NR4A3/PER2/ZFP36/ZFP36L2,7
GO:0051592,BP,GO:0051592,response to calcium ion,6/42,147/18866,8.40911596832229e-07,0.000140432236670982,9.06807593309141e-05,DUSP1/FOS/FOSB/JUN/JUNB/JUND,6
GO:0071277,BP,GO:0071277,cellular response to calcium ion,5/42,83/18866,1.09210985263025e-06,0.000164144110850327,0.000105992135171062,FOS/FOSB/JUN/JUNB/JUND,5
GO:0060537,BP,GO:0060537,muscle tissue development,8/42,409/18866,2.81998699968079e-06,0.000385312769138202,0.000248806508488582,ATF3/BTG2/EGR1/EGR2/FOS/LMNA/SIK1/TIPARP,8
GO:0030099,BP,GO:0030099,myeloid cell differentiation,8/42,431/18866,4.15263782860499e-06,0.000520117888032775,0.000335853691050333,FOS/JUN/JUNB/KLF2/NR4A3/PTPN2/TRIB1/ZFP36,8
GO:0034599,BP,GO:0034599,cellular response to oxidative stress,7/42,310/18866,4.97878193171572e-06,0.000575623787951441,0.000371695298869789,FOS/JUN/KLF2/MCL1/NR4A2/NR4A3/RHOB,7
GO:1901214,BP,GO:1901214,regulation of neuron death,7/42,321/18866,6.25658485299962e-06,0.000671689073861316,0.000433727160486139,BTG2/EGR1/FOS/JUN/MCL1/NR4A2/NR4A3,7
GO:1900153,BP,GO:1900153,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,3/42,18/18866,8.17914231408719e-06,0.000819550059871536,0.000529204857093922,BTG2/ZFP36/ZFP36L2,3
GO:0048545,BP,GO:0048545,response to steroid hormone,7/42,346/18866,1.02013103307592e-05,0.000906537239643558,0.000585374748714053,CLDN4/DUSP1/FOS/FOSB/NR4A3/ZFP36/ZFP36L2,7
GO:1900151,BP,GO:1900151,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,3/42,20/18866,1.13913662987084e-05,0.000906537239643558,0.000585374748714053,BTG2/ZFP36/ZFP36L2,3
GO:1903706,BP,GO:1903706,regulation of hemopoiesis,8/42,498/18866,1.19385230812645e-05,0.000906537239643558,0.000585374748714053,EGR3/FOS/JUN/NR4A3/PTPN2/TRIB1/ZFP36/ZFP36L2,8
GO:0062197,BP,GO:0062197,cellular response to chemical stress,7/42,360/18866,1.3192594884108e-05,0.000906537239643558,0.000585374748714053,FOS/JUN/KLF2/MCL1/NR4A2/NR4A3/RHOB,7
GO:0070997,BP,GO:0070997,neuron death,7/42,360/18866,1.3192594884108e-05,0.000906537239643558,0.000585374748714053,BTG2/EGR1/FOS/JUN/MCL1/NR4A2/NR4A3,7
GO:0036499,BP,GO:0036499,PERK-mediated unfolded protein response,3/42,21/18866,1.3269340833106e-05,0.000906537239643558,0.000585374748714053,ATF3/PPP1R15A/PTPN2,3
GO:0140467,BP,GO:0140467,integrated stress response signaling,3/42,21/18866,1.3269340833106e-05,0.000906537239643558,0.000585374748714053,ATF3/PPP1R15A/PTPN2,3
GO:0042542,BP,GO:0042542,response to hydrogen peroxide,5/42,146/18866,1.75036276473622e-05,0.00113290773045354,0.000731548081015625,DUSP1/JUN/KLF2/NR4A3/RHOB,5
GO:0051384,BP,GO:0051384,response to glucocorticoid,5/42,147/18866,1.80903430012541e-05,0.00113290773045354,0.000731548081015625,DUSP1/FOS/FOSB/ZFP36/ZFP36L2,5
GO:0014706,BP,GO:0014706,striated muscle tissue development,7/42,389/18866,2.17348003624943e-05,0.00126830511635513,0.000818977705837046,ATF3/BTG2/EGR1/EGR2/FOS/LMNA/SIK1,7
GO:0071774,BP,GO:0071774,response to fibroblast growth factor,5/42,153/18866,2.1940075199756e-05,0.00126830511635513,0.000818977705837046,EGR3/IER2/NR4A1/ZFP36/ZFP36L2,5
GO:0045637,BP,GO:0045637,regulation of myeloid cell differentiation,6/42,263/18866,2.38697638332289e-05,0.00132875018671641,0.000858008664882537,FOS/JUN/NR4A3/PTPN2/TRIB1/ZFP36,6
GO:0007519,BP,GO:0007519,skeletal muscle tissue development,5/42,158/18866,2.56112780258318e-05,0.00137477681688661,0.000887729260895372,ATF3/BTG2/EGR1/EGR2/FOS,5
GO:0007517,BP,GO:0007517,muscle organ development,7/42,407/18866,2.90346695032582e-05,0.00150479683666886,0.00097168658010904,ATF3/BTG2/EGR1/EGR2/EGR3/FOS/HBEGF,7
GO:0031960,BP,GO:0031960,response to corticosteroid,5/42,164/18866,3.06287014997517e-05,0.00153449794513756,0.000990865360798985,DUSP1/FOS/FOSB/ZFP36/ZFP36L2,5
GO:0060538,BP,GO:0060538,skeletal muscle organ development,5/42,168/18866,3.4376142523909e-05,0.00165687468207529,0.00106988721285388,ATF3/BTG2/EGR1/EGR2/FOS,5
GO:0043153,BP,GO:0043153,entrainment of circadian clock by photoperiod,3/42,29/18866,3.60065658676894e-05,0.00165687468207529,0.00106988721285388,BHLHE40/PER2/SIK1,3
GO:0034614,BP,GO:0034614,cellular response to reactive oxygen species,5/42,170/18866,3.63784860335892e-05,0.00165687468207529,0.00106988721285388,FOS/JUN/KLF2/NR4A3/RHOB,5
GO:0048660,BP,GO:0048660,regulation of smooth muscle cell proliferation,5/42,173/18866,3.95504051988353e-05,0.00174437065139701,0.00112638564316143,ADAMTS1/HBEGF/JUN/NR4A3/TRIB1,5
GO:1902105,BP,GO:1902105,regulation of leukocyte differentiation,6/42,290/18866,4.12653283535806e-05,0.00174437065139701,0.00112638564316143,EGR3/FOS/JUN/PTPN2/TRIB1/ZFP36L2,6
GO:0048659,BP,GO:0048659,smooth muscle cell proliferation,5/42,175/18866,4.17813329675931e-05,0.00174437065139701,0.00112638564316143,ADAMTS1/HBEGF/JUN/NR4A3/TRIB1,5
GO:0051348,BP,GO:0051348,negative regulation of transferase activity,6/42,296/18866,4.62518999687804e-05,0.00187882717981289,0.00121320773175578,DUSP1/GADD45B/PTPN2/SOCS3/TRIB1/ZFP36,6
GO:0006094,BP,GO:0006094,gluconeogenesis,4/42,91/18866,4.92764995263643e-05,0.00194488071860117,0.00125586022519892,ATF3/PER2/PTPN2/SIK1,4
GO:0001933,BP,GO:0001933,negative regulation of protein phosphorylation,7/42,444/18866,5.04659667501302e-05,0.00194488071860117,0.00125586022519892,ATF3/DUSP1/GADD45B/JUN/PTPN2/SOCS3/TRIB1,7
GO:0009648,BP,GO:0009648,photoperiodism,3/42,33/18866,5.34313635173713e-05,0.00200768348416523,0.00129641360955306,BHLHE40/PER2/SIK1,3
GO:0019319,BP,GO:0019319,hexose biosynthetic process,4/42,94/18866,5.59533751060038e-05,0.00205116884839814,0.0013244932438443,ATF3/PER2/PTPN2/SIK1,4
GO:0009649,BP,GO:0009649,entrainment of circadian clock,3/42,34/18866,5.85114377779156e-05,0.00209387359476684,0.00135206881281299,BHLHE40/PER2/SIK1,3
GO:1901216,BP,GO:1901216,positive regulation of neuron death,4/42,97/18866,6.32679636054972e-05,0.00221143603021075,0.00142798194478013,EGR1/FOS/JUN/MCL1,4
GO:0071248,BP,GO:0071248,cellular response to metal ion,5/42,193/18866,6.65502187190859e-05,0.00227329497124514,0.0014679258770095,FOS/FOSB/JUN/JUNB/JUND,5
GO:0009416,BP,GO:0009416,response to light stimulus,6/42,319/18866,7.00364766076077e-05,0.00228941232467475,0.00147833327264777,BHLHE40/DUSP1/FOS/JUND/PER2/SIK1,6
GO:0046364,BP,GO:0046364,monosaccharide biosynthetic process,4/42,100/18866,7.12567096002322e-05,0.00228941232467475,0.00147833327264777,ATF3/PER2/PTPN2/SIK1,4
GO:0007565,BP,GO:0007565,female pregnancy,5/42,196/18866,7.15917360344067e-05,0.00228941232467475,0.00147833327264777,CLDN4/FOS/FOSB/JUNB/TPPP3,5
GO:1901654,BP,GO:1901654,response to ketone,5/42,200/18866,7.87666272864002e-05,0.00245255032182087,0.00158367573394883,CLDN4/DUSP1/FOS/FOSB/KLF2,5
GO:0048661,BP,GO:0048661,positive regulation of smooth muscle cell proliferation,4/42,103/18866,7.99567303853776e-05,0.00245255032182087,0.00158367573394883,ADAMTS1/HBEGF/JUN/NR4A3,4
GO:0042326,BP,GO:0042326,negative regulation of phosphorylation,7/42,484/18866,8.679039187834e-05,0.0026089191798629,0.0016846471855122,ATF3/DUSP1/GADD45B/JUN/PTPN2/SOCS3/TRIB1,7
GO:1902895,BP,GO:1902895,positive regulation of pri-miRNA transcription by RNA polymerase II,3/42,40/18866,9.57129623802789e-05,0.0028207173030894,0.00182141075984762,EGR1/FOS/JUN,3
GO:0002573,BP,GO:0002573,myeloid leukocyte differentiation,5/42,210/18866,9.91374707500316e-05,0.00282570461144493,0.00182463119498002,FOS/JUN/JUNB/PTPN2/TRIB1,5
GO:0043618,BP,GO:0043618,regulation of transcription from RNA polymerase II promoter in response to stress,4/42,109/18866,9.96422783809589e-05,0.00282570461144493,0.00182463119498002,ATF3/EGR1/JUN/KLF2,4
GO:0043523,BP,GO:0043523,regulation of neuron apoptotic process,5/42,214/18866,0.00010833338861771,0.00301527931652626,0.00194704452837288,BTG2/JUN/MCL1/NR4A2/NR4A3,5
GO:0043620,BP,GO:0043620,regulation of DNA-templated transcription in response to stress,4/42,115/18866,0.000122634053499389,0.00335125422562876,0.00216399229332893,ATF3/EGR1/JUN/KLF2,4
GO:0071241,BP,GO:0071241,cellular response to inorganic substance,5/42,221/18866,0.000125990206113606,0.00338148713908482,0.0021835144743749,FOS/FOSB/JUN/JUNB/JUND,5
GO:0044706,BP,GO:0044706,multi-multicellular organism process,5/42,226/18866,0.000139897046731611,0.0036888642322388,0.00238199588340804,CLDN4/FOS/FOSB/JUNB/TPPP3,5
GO:0032570,BP,GO:0032570,response to progesterone,3/42,46/18866,0.000145697381180907,0.00377557179163626,0.00243798521685655,CLDN4/FOS/FOSB,3
GO:0010038,BP,GO:0010038,response to metal ion,6/42,366/18866,0.000148794135879072,0.00379046756315671,0.00244760380518296,DUSP1/FOS/FOSB/JUN/JUNB/JUND,6
GO:0002761,BP,GO:0002761,regulation of myeloid leukocyte differentiation,4/42,123/18866,0.000158984740351688,0.00398256774580979,0.00257164790533784,FOS/JUN/PTPN2/TRIB1,4
GO:0030968,BP,GO:0030968,endoplasmic reticulum unfolded protein response,4/42,125/18866,0.000169170138164535,0.00416824127313599,0.00269154214646594,ATF3/LMNA/PPP1R15A/PTPN2,4
GO:0061014,BP,GO:0061014,positive regulation of mRNA catabolic process,3/42,50/18866,0.000186959558701325,0.0044603209004459,0.00288014558266703,BTG2/ZFP36/ZFP36L2,3
GO:1904707,BP,GO:1904707,positive regulation of vascular associated smooth muscle cell proliferation,3/42,50/18866,0.000186959558701325,0.0044603209004459,0.00288014558266703,ADAMTS1/JUN/NR4A3,3
GO:0006984,BP,GO:0006984,ER-nucleus signaling pathway,3/42,51/18866,0.000198337405320853,0.00455290290662493,0.00293992819967657,ATF3/PPP1R15A/PTPN2,3
GO:1902893,BP,GO:1902893,regulation of pri-miRNA transcription by RNA polymerase II,3/42,51/18866,0.000198337405320853,0.00455290290662493,0.00293992819967657,EGR1/FOS/JUN,3
GO:0033002,BP,GO:0033002,muscle cell proliferation,5/42,244/18866,0.000199927872147202,0.00455290290662493,0.00293992819967657,ADAMTS1/HBEGF/JUN/NR4A3/TRIB1,5
GO:0051402,BP,GO:0051402,neuron apoptotic process,5/42,245/18866,0.000203759720498015,0.00457090835684352,0.00295155478867509,BTG2/JUN/MCL1/NR4A2/NR4A3,5
GO:0006469,BP,GO:0006469,negative regulation of protein kinase activity,5/42,246/18866,0.000207647427722137,0.00457772646252012,0.00295595741740627,DUSP1/GADD45B/PTPN2/SOCS3/TRIB1,5
GO:0038066,BP,GO:0038066,p38MAPK cascade,3/42,52/18866,0.000210155107061802,0.00457772646252012,0.00295595741740627,DUSP1/GADD45B/ZFP36,3
GO:1903897,BP,GO:1903897,regulation of PERK-mediated unfolded protein response,2/42,10/18866,0.000215276422149212,0.00462229232128951,0.00298473475521163,PPP1R15A/PTPN2,2
GO:0061614,BP,GO:0061614,pri-miRNA transcription by RNA polymerase II,3/42,53/18866,0.000222420039781784,0.00470841295481721,0.00304034509531216,EGR1/FOS/JUN,3
GO:1901991,BP,GO:1901991,negative regulation of mitotic cell cycle phase transition,5/42,251/18866,0.000227943104729165,0.00475831231122133,0.00307256641170015,BTG2/DUSP1/PLK3/WEE1/ZFP36L2,5
GO:1901653,BP,GO:1901653,cellular response to peptide,6/42,398/18866,0.000234210653191394,0.00480293294862904,0.00310137912150154,KLF2/NR4A1/NR4A2/NR4A3/PTPN2/SOCS3,6
GO:0031668,BP,GO:0031668,cellular response to extracellular stimulus,5/42,253/18866,0.000236471748635096,0.00480293294862904,0.00310137912150154,ATF3/FOS/JUN/NR4A2/SIK1,5
GO:0002763,BP,GO:0002763,positive regulation of myeloid leukocyte differentiation,3/42,58/18866,0.00029070770948527,0.00582578249808481,0.00376185976344447,FOS/JUN/TRIB1,3
GO:0048008,BP,GO:0048008,platelet-derived growth factor receptor signaling pathway,3/42,59/18866,0.000305808035662449,0.00586824166279326,0.0037892767539275,NR4A3/PTPN2/TIPARP,3
GO:0034620,BP,GO:0034620,cellular response to unfolded protein,4/42,146/18866,0.000306538138827794,0.00586824166279326,0.0037892767539275,ATF3/LMNA/PPP1R15A/PTPN2,4
GO:0044344,BP,GO:0044344,cellular response to fibroblast growth factor stimulus,4/42,146/18866,0.000306538138827794,0.00586824166279326,0.0037892767539275,EGR3/NR4A1/ZFP36/ZFP36L2,4
GO:0033673,BP,GO:0033673,negative regulation of kinase activity,5/42,268/18866,0.00030844383989399,0.00586824166279326,0.0037892767539275,DUSP1/GADD45B/PTPN2/SOCS3/TRIB1,5
GO:0060213,BP,GO:0060213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,2/42,12/18866,0.000314847751577441,0.00591520213276117,0.00381960035466316,BTG2/ZFP36,2
GO:1901988,BP,GO:1901988,negative regulation of cell cycle phase transition,5/42,270/18866,0.000319170614708971,0.00592238807293313,0.00382424050372542,BTG2/DUSP1/PLK3/WEE1/ZFP36L2,5
GO:0043524,BP,GO:0043524,negative regulation of neuron apoptotic process,4/42,149/18866,0.000331199326777099,0.00607064131885342,0.00391997149279186,BTG2/JUN/NR4A2/NR4A3,4
GO:0061469,BP,GO:0061469,regulation of type B pancreatic cell proliferation,2/42,13/18866,0.000371567520445451,0.00672850582204233,0.0043447717672886,NR4A1/NR4A3,2
GO:1902107,BP,GO:1902107,positive regulation of leukocyte differentiation,4/42,159/18866,0.000423712716832754,0.00752958570317059,0.00486204994805006,EGR3/FOS/JUN/TRIB1,4
GO:0032922,BP,GO:0032922,circadian regulation of gene expression,3/42,66/18866,0.000425824873432801,0.00752958570317059,0.00486204994805006,BHLHE40/EGR1/PER2,3
GO:0060211,BP,GO:0060211,regulation of nuclear-transcribed mRNA poly(A) tail shortening,2/42,14/18866,0.000432883567194337,0.0075653953661987,0.00488517318180145,BTG2/ZFP36,2
GO:1901990,BP,GO:1901990,regulation of mitotic cell cycle phase transition,6/42,448/18866,0.00044068611624606,0.00761323255997503,0.0049160629059754,ADAMTS1/BTG2/DUSP1/PLK3/WEE1/ZFP36L2,6
GO:0034976,BP,GO:0034976,response to endoplasmic reticulum stress,5/42,294/18866,0.000471233727925442,0.00798501494922698,0.00515613249514114,ATF3/JUN/LMNA/PPP1R15A/PTPN2,5
GO:0009896,BP,GO:0009896,positive regulation of catabolic process,6/42,454/18866,0.000472831889874385,0.00798501494922698,0.00515613249514114,BTG2/PLK3/TIPARP/TRIB1/ZFP36/ZFP36L2,6
GO:0007093,BP,GO:0007093,mitotic cell cycle checkpoint,4/42,166/18866,0.000498577814257597,0.00823475225086999,0.00531739438687686,BTG2/DUSP1/PLK3/WEE1,4
GO:0035967,BP,GO:0035967,cellular response to topologically incorrect protein,4/42,166/18866,0.000498577814257597,0.00823475225086999,0.00531739438687686,ATF3/LMNA/PPP1R15A/PTPN2,4
GO:0042532,BP,GO:0042532,negative regulation of tyrosine phosphorylation of STAT protein,2/42,16/18866,0.000569225490337137,0.00929941208670344,0.00600487302163433,PTPN2/SOCS3,2
GO:0033077,BP,GO:0033077,T cell differentiation in thymus,3/42,76/18866,0.000644153487892505,0.0103005389781733,0.00665132677653521,EGR3/PTPN2/ZFP36L2,3
GO:0061158,BP,GO:0061158,3'-UTR-mediated mRNA destabilization,2/42,17/18866,0.000644212018595004,0.0103005389781733,0.00665132677653521,ZFP36/ZFP36L2,2
GO:1901987,BP,GO:1901987,regulation of cell cycle phase transition,6/42,486/18866,0.000676541931073552,0.0107036054989847,0.00691159734570432,ADAMTS1/BTG2/DUSP1/PLK3/WEE1/ZFP36L2,6
GO:0000288,BP,GO:0000288,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,3/42,78/18866,0.000694928364569777,0.0108799722077956,0.00702548193128656,BTG2/ZFP36/ZFP36L2,3
GO:0006986,BP,GO:0006986,response to unfolded protein,4/42,183/18866,0.000718996980774101,0.0109873266725209,0.00709480351021765,ATF3/LMNA/PPP1R15A/PTPN2,4
GO:0070373,BP,GO:0070373,negative regulation of ERK1 and ERK2 cascade,3/42,79/18866,0.000721244922655184,0.0109873266725209,0.00709480351021765,ATF3/DUSP1/PTPN2,3
GO:0035994,BP,GO:0035994,response to muscle stretch,2/42,18/18866,0.000723716128130119,0.0109873266725209,0.00709480351021765,FOS/JUN,2
GO:0070371,BP,GO:0070371,ERK1 and ERK2 cascade,5/42,325/18866,0.000741899908327352,0.0110842754314662,0.00715740585342428,ATF3/DUSP1/JUN/PTPN2/ZFP36L2,5
GO:2000045,BP,GO:2000045,regulation of G1/S transition of mitotic cell cycle,4/42,185/18866,0.000748809094575166,0.0110842754314662,0.00715740585342428,ADAMTS1/BTG2/PLK3/WEE1,4
GO:0071496,BP,GO:0071496,cellular response to external stimulus,5/42,326/18866,0.000752226276786131,0.0110842754314662,0.00715740585342428,ATF3/FOS/JUN/NR4A2/SIK1,5
GO:0071375,BP,GO:0071375,cellular response to peptide hormone stimulus,5/42,330/18866,0.000794613052504162,0.0115951788146967,0.00748730949830186,NR4A1/NR4A2/NR4A3/PTPN2/SOCS3,5
GO:1903313,BP,GO:1903313,positive regulation of mRNA metabolic process,3/42,82/18866,0.00080398355649497,0.0116191085135763,0.00750276152923444,BTG2/ZFP36/ZFP36L2,3
GO:0051412,BP,GO:0051412,response to corticosterone,2/42,20/18866,0.000896199068180113,0.0127074264101388,0.00820551679108306,FOS/FOSB,2
GO:0070262,BP,GO:0070262,peptidyl-serine dephosphorylation,2/42,20/18866,0.000896199068180113,0.0127074264101388,0.00820551679108306,DUSP1/PPP1R15A,2
GO:0045930,BP,GO:0045930,negative regulation of mitotic cell cycle,5/42,341/18866,0.000920415126565091,0.0128501468857615,0.00829767512600913,BTG2/DUSP1/PLK3/WEE1/ZFP36L2,5
GO:0014910,BP,GO:0014910,regulation of smooth muscle cell migration,3/42,86/18866,0.000923363848078673,0.0128501468857615,0.00829767512600913,ADAMTS1/NR4A3/TRIB1,3
GO:1904705,BP,GO:1904705,regulation of vascular associated smooth muscle cell proliferation,3/42,87/18866,0.000954865974194823,0.0130469414474074,0.00842475050916389,ADAMTS1/JUN/NR4A3,3
GO:1990874,BP,GO:1990874,vascular associated smooth muscle cell proliferation,3/42,87/18866,0.000954865974194823,0.0130469414474074,0.00842475050916389,ADAMTS1/JUN/NR4A3,3
GO:1903708,BP,GO:1903708,positive regulation of hemopoiesis,4/42,204/18866,0.00107718381266356,0.0145806952372052,0.0094151353494437,EGR3/FOS/JUN/TRIB1,4
GO:0044342,BP,GO:0044342,type B pancreatic cell proliferation,2/42,22/18866,0.00108651887329806,0.0145806952372052,0.0094151353494437,NR4A1/NR4A3,2
GO:0035966,BP,GO:0035966,response to topologically incorrect protein,4/42,205/18866,0.00109685908934164,0.0145891965600042,0.00942062487538881,ATF3/LMNA/PPP1R15A/PTPN2,4
GO:0042594,BP,GO:0042594,response to starvation,4/42,206/18866,0.00111678591266381,0.0145959063194236,0.00942495754211473,ATF3/JUN/SIK1/ZFP36,4
GO:1902806,BP,GO:1902806,regulation of cell cycle G1/S phase transition,4/42,206/18866,0.00111678591266381,0.0145959063194236,0.00942495754211473,ADAMTS1/BTG2/PLK3/WEE1,4
GO:0010948,BP,GO:0010948,negative regulation of cell cycle process,5/42,359/18866,0.00115760991453042,0.014878855086199,0.00960766494342924,BTG2/DUSP1/PLK3/WEE1/ZFP36L2,5
GO:0014909,BP,GO:0014909,smooth muscle cell migration,3/42,93/18866,0.00115823422826698,0.014878855086199,0.00960766494342924,ADAMTS1/NR4A3/TRIB1,3
GO:0009612,BP,GO:0009612,response to mechanical stimulus,4/42,209/18866,0.00117809325104508,0.0149620287975882,0.00966137237901483,BTG2/FOS/FOSB/JUN,4
GO:0045649,BP,GO:0045649,regulation of macrophage differentiation,2/42,23/18866,0.00118831929150016,0.0149620287975882,0.00966137237901483,PTPN2/TRIB1,2
GO:0051591,BP,GO:0051591,response to cAMP,3/42,94/18866,0.00119457315749207,0.0149620287975882,0.00966137237901483,DUSP1/FOS/FOSB,3
GO:0050679,BP,GO:0050679,positive regulation of epithelial cell proliferation,4/42,211/18866,0.00122025478596959,0.0149666552122958,0.00966435977570241,EGR3/JUN/NR4A1/NR4A3,4
GO:0045638,BP,GO:0045638,negative regulation of myeloid cell differentiation,3/42,95/18866,0.00123162492582321,0.0149666552122958,0.00966435977570241,PTPN2/TRIB1/ZFP36,3
GO:1901215,BP,GO:1901215,negative regulation of neuron death,4/42,212/18866,0.00124172782061664,0.0149666552122958,0.00966435977570241,BTG2/JUN/NR4A2/NR4A3,4
GO:0010631,BP,GO:0010631,epithelial cell migration,5/42,365/18866,0.00124594832393006,0.0149666552122958,0.00966435977570241,EGR3/HBEGF/JUN/NR4A1/RHOB,5
GO:0016051,BP,GO:0016051,carbohydrate biosynthetic process,4/42,213/18866,0.00126346471011063,0.0149666552122958,0.00966435977570241,ATF3/PER2/PTPN2/SIK1,4
GO:0006006,BP,GO:0006006,glucose metabolic process,4/42,214/18866,0.0012854672114724,0.0149666552122958,0.00966435977570241,ATF3/PER2/PTPN2/SIK1,4
GO:0030098,BP,GO:0030098,lymphocyte differentiation,5/42,368/18866,0.0012919487715061,0.0149666552122958,0.00966435977570241,EGR1/EGR3/KLF6/PTPN2/ZFP36L2,5
GO:0090132,BP,GO:0090132,epithelium migration,5/42,368/18866,0.0012919487715061,0.0149666552122958,0.00966435977570241,EGR3/HBEGF/JUN/NR4A1/RHOB,5
GO:0036003,BP,GO:0036003,positive regulation of transcription from RNA polymerase II promoter in response to stress,2/42,24/18866,0.00129452107624647,0.0149666552122958,0.00966435977570241,ATF3/KLF2,2
GO:2000209,BP,GO:2000209,regulation of anoikis,2/42,24/18866,0.00129452107624647,0.0149666552122958,0.00966435977570241,MCL1/SIK1,2
GO:0090130,BP,GO:0090130,tissue migration,5/42,374/18866,0.00138771622746312,0.015643503110771,0.0101014181238442,EGR3/HBEGF/JUN/NR4A1/RHOB,5
GO:0000075,BP,GO:0000075,cell cycle checkpoint,4/42,219/18866,0.00139952535562115,0.015643503110771,0.0101014181238442,BTG2/DUSP1/PLK3/WEE1,4
GO:0046697,BP,GO:0046697,decidualization,2/42,25/18866,0.00140510506982973,0.015643503110771,0.0101014181238442,JUNB/TPPP3,2
GO:0060330,BP,GO:0060330,regulation of response to interferon-gamma,2/42,25/18866,0.00140510506982973,0.015643503110771,0.0101014181238442,PTPN2/SOCS3,2
GO:0060334,BP,GO:0060334,regulation of interferon-gamma-mediated signaling pathway,2/42,25/18866,0.00140510506982973,0.015643503110771,0.0101014181238442,PTPN2/SOCS3,2
GO:0070301,BP,GO:0070301,cellular response to hydrogen peroxide,3/42,100/18866,0.00142776161510937,0.0157788654963925,0.0101888251480715,KLF2/NR4A3/RHOB,3
GO:0045639,BP,GO:0045639,positive regulation of myeloid cell differentiation,3/42,101/18866,0.00146920097575096,0.0161183143544065,0.0104080161324809,FOS/JUN/TRIB1,3
GO:0031664,BP,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,2/42,26/18866,0.00152005217451272,0.016436247613616,0.0106133139333641,CD55/TRIB1,2
GO:1904754,BP,GO:1904754,positive regulation of vascular associated smooth muscle cell migration,2/42,26/18866,0.00152005217451272,0.016436247613616,0.0106133139333641,ADAMTS1/NR4A3,2
GO:0032897,BP,GO:0032897,negative regulation of viral transcription,2/42,27/18866,0.00163934335236632,0.0172303011091369,0.0111260549936087,JUN/ZFP36,2
GO:0033081,BP,GO:0033081,regulation of T cell differentiation in thymus,2/42,27/18866,0.00163934335236632,0.0172303011091369,0.0111260549936087,EGR3/PTPN2,2
GO:0046426,BP,GO:0046426,negative regulation of receptor signaling pathway via JAK-STAT,2/42,27/18866,0.00163934335236632,0.0172303011091369,0.0111260549936087,PTPN2/SOCS3,2
GO:1903203,BP,GO:1903203,regulation of oxidative stress-induced neuron death,2/42,27/18866,0.00163934335236632,0.0172303011091369,0.0111260549936087,MCL1/NR4A3,2
GO:0031331,BP,GO:0031331,positive regulation of cellular catabolic process,5/42,390/18866,0.00166879145431386,0.017418010804401,0.0112472640415013,BTG2/PLK3/TRIB1/ZFP36/ZFP36L2,5
GO:0014812,BP,GO:0014812,muscle cell migration,3/42,106/18866,0.00168773733218611,0.0174942704156947,0.0112965068622548,ADAMTS1/NR4A3/TRIB1,3
GO:1900101,BP,GO:1900101,regulation of endoplasmic reticulum unfolded protein response,2/42,28/18866,0.00176295962510798,0.0180427888914459,0.0116506995538139,PPP1R15A/PTPN2,2
GO:0050678,BP,GO:0050678,regulation of epithelial cell proliferation,5/42,395/18866,0.00176466398339491,0.0180427888914459,0.0116506995538139,EGR3/JUN/NR4A1/NR4A3/ZFP36,5
GO:0007050,BP,GO:0007050,cell cycle arrest,4/42,234/18866,0.00178399561478932,0.018117198709651,0.0116987479149058,BTG2/DUSP1/PLK3/PPP1R15A,4
GO:0036475,BP,GO:0036475,neuron death in response to oxidative stress,2/42,30/18866,0.00202309183939174,0.0203038226058849,0.0131107080173869,MCL1/NR4A3,2
GO:0001938,BP,GO:0001938,positive regulation of endothelial cell proliferation,3/42,113/18866,0.00202632960138572,0.0203038226058849,0.0131107080173869,EGR3/JUN/NR4A1,3
GO:2001233,BP,GO:2001233,regulation of apoptotic signaling pathway,5/42,413/18866,0.00214363530422124,0.0213369792201624,0.0137778442000138,ATF3/LMNA/MCL1/NR4A2/PTPN2,5
GO:0006352,BP,GO:0006352,DNA-templated transcription, initiation,4/42,249/18866,0.00223648222013987,0.0221146893215146,0.0142800319042172,JUN/NR4A1/NR4A2/NR4A3,4
GO:0035767,BP,GO:0035767,endothelial cell chemotaxis,2/42,32/18866,0.00230029817792179,0.0223054720091384,0.014403225263456,EGR3/NR4A1,2
GO:0051385,BP,GO:0051385,response to mineralocorticoid,2/42,32/18866,0.00230029817792179,0.0223054720091384,0.014403225263456,FOS/FOSB,2
GO:0061157,BP,GO:0061157,mRNA destabilization,2/42,32/18866,0.00230029817792179,0.0223054720091384,0.014403225263456,ZFP36/ZFP36L2,2
GO:0030217,BP,GO:0030217,T cell differentiation,4/42,253/18866,0.00236937656771033,0.0228280319312092,0.0147406558396014,EGR1/EGR3/PTPN2/ZFP36L2,4
GO:0019318,BP,GO:0019318,hexose metabolic process,4/42,254/18866,0.00240343337275138,0.023008664708569,0.0148572951369546,ATF3/PER2/PTPN2/SIK1,4
GO:0046627,BP,GO:0046627,negative regulation of insulin receptor signaling pathway,2/42,33/18866,0.00244525732723821,0.0231146022820064,0.014925701792212,PTPN2/SOCS3,2
GO:1904893,BP,GO:1904893,negative regulation of receptor signaling pathway via STAT,2/42,33/18866,0.00244525732723821,0.0231146022820064,0.014925701792212,PTPN2/SOCS3,2
GO:0030218,BP,GO:0030218,erythrocyte differentiation,3/42,121/18866,0.00246179475660958,0.0231254844949012,0.0149327287210134,KLF2/PTPN2/ZFP36,3
GO:0042752,BP,GO:0042752,regulation of circadian rhythm,3/42,122/18866,0.00251997289155125,0.0235249643229909,0.0151906832691092,BHLHE40/PER2/SIK1,3
GO:0043276,BP,GO:0043276,anoikis,2/42,34/18866,0.00259442894532947,0.0239228632198172,0.0154476169686392,MCL1/SIK1,2
GO:0070102,BP,GO:0070102,interleukin-6-mediated signaling pathway,2/42,34/18866,0.00259442894532947,0.0239228632198172,0.0154476169686392,PTPN2/SOCS3,2
GO:0007611,BP,GO:0007611,learning or memory,4/42,260/18866,0.00261490397301906,0.0239646382405344,0.0154745921894966,BTG2/EGR2/FOS/JUN,4
GO:0050779,BP,GO:0050779,RNA destabilization,2/42,35/18866,0.00274779446694938,0.0247028152116605,0.0159512523200273,ZFP36/ZFP36L2,2
GO:0060674,BP,GO:0060674,placenta blood vessel development,2/42,35/18866,0.00274779446694938,0.0247028152116605,0.0159512523200273,JUNB/SOCS3,2
GO:1900077,BP,GO:1900077,negative regulation of cellular response to insulin stimulus,2/42,35/18866,0.00274779446694938,0.0247028152116605,0.0159512523200273,PTPN2/SOCS3,2
GO:2000134,BP,GO:2000134,negative regulation of G1/S transition of mitotic cell cycle,3/42,126/18866,0.00276119291787024,0.0247028152116605,0.0159512523200273,BTG2/PLK3/WEE1,3
GO:0030522,BP,GO:0030522,intracellular receptor signaling pathway,4/42,265/18866,0.00280065179650443,0.024907571894356,0.0160834690524889,KLF2/NR4A1/NR4A2/NR4A3,4
GO:0048608,BP,GO:0048608,reproductive structure development,5/42,443/18866,0.00290320636969735,0.0253879016510814,0.016393630509015,ADAMTS1/JUNB/SOCS3/TIPARP/TPPP3,5
GO:0000289,BP,GO:0000289,nuclear-transcribed mRNA poly(A) tail shortening,2/42,36/18866,0.00290533538522023,0.0253879016510814,0.016393630509015,BTG2/ZFP36,2
GO:0001893,BP,GO:0001893,maternal placenta development,2/42,36/18866,0.00290533538522023,0.0253879016510814,0.016393630509015,JUNB/TPPP3,2
GO:0034101,BP,GO:0034101,erythrocyte homeostasis,3/42,129/18866,0.00295115624361769,0.0256392360355919,0.0165559236788288,KLF2/PTPN2/ZFP36,3
GO:0061458,BP,GO:0061458,reproductive system development,5/42,447/18866,0.00301752815879277,0.0260652001302617,0.0168309798088744,ADAMTS1/JUNB/SOCS3/TIPARP/TPPP3,5
GO:0006417,BP,GO:0006417,regulation of translation,5/42,450/18866,0.00310539016348169,0.0266708652326456,0.0172220735683015,BTG2/PER2/PPP1R15A/ZFP36/ZFP36L2,5
GO:1902807,BP,GO:1902807,negative regulation of cell cycle G1/S phase transition,3/42,132/18866,0.00314899585390142,0.0268917089114422,0.0173646780938822,BTG2/PLK3/WEE1,3
GO:0050673,BP,GO:0050673,epithelial cell proliferation,5/42,453/18866,0.00319509456324018,0.0271312267149717,0.0175193409890422,EGR3/JUN/NR4A1/NR4A3/ZFP36,5
GO:0071276,BP,GO:0071276,cellular response to cadmium ion,2/42,38/18866,0.00323286967509917,0.0271452688361679,0.017528408353081,FOS/JUN,2
GO:1905898,BP,GO:1905898,positive regulation of response to endoplasmic reticulum stress,2/42,38/18866,0.00323286967509917,0.0271452688361679,0.017528408353081,PPP1R15A/PTPN2,2
GO:0051090,BP,GO:0051090,regulation of DNA-binding transcription factor activity,5/42,455/18866,0.00325593202496248,0.0271870324084367,0.0175553761813766,BHLHE40/FOS/JUN/SIK1/TRIB1,5
GO:0046683,BP,GO:0046683,response to organophosphorus,3/42,134/18866,0.00328531675392773,0.0272808347025048,0.0176159467701155,DUSP1/FOS/FOSB,3
GO:0001825,BP,GO:0001825,blastocyst formation,2/42,39/18866,0.00340282632337462,0.0281013624397365,0.0181457829389901,JUNB/TM4SF1,2
GO:0030183,BP,GO:0030183,B cell differentiation,3/42,137/18866,0.00349651599964081,0.0286525780582086,0.0185017172459771,KLF6/PTPN2/ZFP36L2,3
GO:0002683,BP,GO:0002683,negative regulation of immune system process,5/42,463/18866,0.00350770084012667,0.0286525780582086,0.0185017172459771,CD55/DUSP1/PTPN2/TRIB1/ZFP36,5
GO:0032868,BP,GO:0032868,response to insulin,4/42,283/18866,0.00354436005896988,0.0287955306412526,0.0185940254587211,EGR1/EGR2/PTPN2/SOCS3,4
GO:0051403,BP,GO:0051403,stress-activated MAPK cascade,4/42,286/18866,0.00368017623748042,0.0297381983060918,0.0192027305656873,DUSP1/GADD45B/TRIB1/ZFP36,4
GO:0000082,BP,GO:0000082,G1/S transition of mitotic cell cycle,4/42,287/18866,0.00372622545237241,0.0299492879942018,0.0193390366849838,ADAMTS1/BTG2/PLK3/WEE1,4
GO:0007612,BP,GO:0007612,learning,3/42,145/18866,0.00409982422093023,0.0326327419851438,0.0210718129427479,BTG2/FOS/JUN,3
GO:0071364,BP,GO:0071364,cellular response to epidermal growth factor stimulus,2/42,43/18866,0.0041234905261985,0.0326327419851438,0.0210718129427479,ZFP36/ZFP36L2,2
GO:0001667,BP,GO:0001667,ameboidal-type cell migration,5/42,481/18866,0.00412523019106941,0.0326327419851438,0.0210718129427479,EGR3/HBEGF/JUN/NR4A1/RHOB,5
GO:0005996,BP,GO:0005996,monosaccharide metabolic process,4/42,296/18866,0.00415846629827277,0.0327234285146805,0.0211303716010333,ATF3/PER2/PTPN2/SIK1,4
GO:0042110,BP,GO:0042110,T cell activation,5/42,483/18866,0.00419836138997116,0.0327739640373645,0.0211630037065869,CD55/EGR1/EGR3/PTPN2/ZFP36L2,5
GO:0071356,BP,GO:0071356,cellular response to tumor necrosis factor,4/42,297/18866,0.00420849970672744,0.0327739640373645,0.0211630037065869,KLF2/PTPN2/ZFP36/ZFP36L2,4
GO:0031098,BP,GO:0031098,stress-activated protein kinase signaling cascade,4/42,300/18866,0.00436104885603418,0.0337868888176256,0.021817075666107,DUSP1/GADD45B/TRIB1/ZFP36,4
GO:0014074,BP,GO:0014074,response to purine-containing compound,3/42,149/18866,0.00442377828604838,0.0340971218663114,0.0220174012401436,DUSP1/FOS/FOSB,3
GO:0050890,BP,GO:0050890,cognition,4/42,302/18866,0.00446480467020258,0.0342377623434412,0.0221082164657722,BTG2/EGR2/FOS/JUN,4
GO:0070372,BP,GO:0070372,regulation of ERK1 and ERK2 cascade,4/42,306/18866,0.00467730747588769,0.0356852443464934,0.0230428933623748,ATF3/DUSP1/JUN/PTPN2,4
GO:1900744,BP,GO:1900744,regulation of p38MAPK cascade,2/42,46/18866,0.00470636128901621,0.0357255606938958,0.0230689266798136,DUSP1/GADD45B,2
GO:0002262,BP,GO:0002262,myeloid cell homeostasis,3/42,154/18866,0.00485005299916411,0.0361650287195361,0.0233527026504271,KLF2/PTPN2/ZFP36,3
GO:0044843,BP,GO:0044843,cell cycle G1/S phase transition,4/42,310/18866,0.00489654727912439,0.0361650287195361,0.0233527026504271,ADAMTS1/BTG2/PLK3/WEE1,4
GO:0030225,BP,GO:0030225,macrophage differentiation,2/42,47/18866,0.00490862665255181,0.0361650287195361,0.0233527026504271,PTPN2/TRIB1,2
GO:0070849,BP,GO:0070849,response to epidermal growth factor,2/42,47/18866,0.00490862665255181,0.0361650287195361,0.0233527026504271,ZFP36/ZFP36L2,2
GO:1904738,BP,GO:1904738,vascular associated smooth muscle cell migration,2/42,47/18866,0.00490862665255181,0.0361650287195361,0.0233527026504271,ADAMTS1/NR4A3,2
GO:1904752,BP,GO:1904752,regulation of vascular associated smooth muscle cell migration,2/42,47/18866,0.00490862665255181,0.0361650287195361,0.0233527026504271,ADAMTS1/NR4A3,2
GO:0060326,BP,GO:0060326,cell chemotaxis,4/42,311/18866,0.00495242134983464,0.036309703847812,0.0234461231555714,DUSP1/EGR3/HBEGF/NR4A1,4
GO:0001890,BP,GO:0001890,placenta development,3/42,156/18866,0.00502728115249369,0.0366796289912525,0.0236849934726581,JUNB/SOCS3/TPPP3,3
GO:0014911,BP,GO:0014911,positive regulation of smooth muscle cell migration,2/42,48/18866,0.0051148498258321,0.0371382574310418,0.0239811418226148,ADAMTS1/NR4A3,2
GO:1903707,BP,GO:1903707,negative regulation of hemopoiesis,3/42,158/18866,0.00520838517129389,0.0376355909252631,0.024302283036098,PTPN2/TRIB1/ZFP36,3
GO:0006111,BP,GO:0006111,regulation of gluconeogenesis,2/42,49/18866,0.00532501304653427,0.0379312540708104,0.024493200443525,PTPN2/SIK1,2
GO:0042059,BP,GO:0042059,negative regulation of epidermal growth factor receptor signaling pathway,2/42,49/18866,0.00532501304653427,0.0379312540708104,0.024493200443525,HBEGF/PTPN2,2
GO:0060711,BP,GO:0060711,labyrinthine layer development,2/42,49/18866,0.00532501304653427,0.0379312540708104,0.024493200443525,JUNB/SOCS3,2
GO:0007568,BP,GO:0007568,aging,4/42,319/18866,0.00541497304613578,0.0383901155110476,0.0247894992479503,FOS/JUN/JUND/LMNA,4
GO:0034612,BP,GO:0034612,response to tumor necrosis factor,4/42,320/18866,0.00547475935891106,0.0386317526593584,0.0249455306593329,KLF2/PTPN2/ZFP36/ZFP36L2,4
GO:0007622,BP,GO:0007622,rhythmic behavior,2/42,50/18866,0.00553909860852731,0.0389031084514792,0.0251207521744328,EGR1/EGR2,2
GO:2001236,BP,GO:2001236,regulation of extrinsic apoptotic signaling pathway,3/42,162/18866,0.00558231567917085,0.0390242812362502,0.0251989966031605,ATF3/LMNA/MCL1,3
GO:0009267,BP,GO:0009267,cellular response to starvation,3/42,163/18866,0.00567825735783825,0.0395112074482911,0.0255134175629964,ATF3/JUN/SIK1,3
GO:0002762,BP,GO:0002762,negative regulation of myeloid leukocyte differentiation,2/42,51/18866,0.0057570888617194,0.0396922227484599,0.025630303865308,PTPN2/TRIB1,2
GO:0071354,BP,GO:0071354,cellular response to interleukin-6,2/42,51/18866,0.0057570888617194,0.0396922227484599,0.025630303865308,PTPN2/SOCS3,2
GO:1903037,BP,GO:1903037,regulation of leukocyte cell-cell adhesion,4/42,329/18866,0.00603290859062764,0.0414039343000609,0.0267356006756005,CD55/EGR3/NR4A3/PTPN2,4
GO:0043392,BP,GO:0043392,negative regulation of DNA binding,2/42,53/18866,0.00620471312061644,0.0423894719103933,0.0273719880249204,JUN/PER2,2
GO:0038095,BP,GO:0038095,Fc-epsilon receptor signaling pathway,3/42,169/18866,0.00627477817552643,0.0426741701258652,0.0275558250909043,FOS/JUN/NR4A3,3
GO:0032496,BP,GO:0032496,response to lipopolysaccharide,4/42,334/18866,0.00635885762137929,0.0430511847069057,0.0277992732428246,CD55/FOS/TRIB1/ZFP36,4
GO:1901185,BP,GO:1901185,negative regulation of ERBB signaling pathway,2/42,54/18866,0.00643431210496546,0.043366686519117,0.0280030009949406,HBEGF/PTPN2,2
GO:0002931,BP,GO:0002931,response to ischemia,2/42,55/18866,0.00666774573749908,0.0445405415264938,0.0287609898010486,EGR1/PER2,2
GO:0070741,BP,GO:0070741,response to interleukin-6,2/42,55/18866,0.00666774573749908,0.0445405415264938,0.0287609898010486,PTPN2/SOCS3,2
GO:0006977,BP,GO:0006977,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,2/42,56/18866,0.00690499664604537,0.0457189866035515,0.0295219425349123,BTG2/PLK3,2
GO:0050732,BP,GO:0050732,negative regulation of peptidyl-tyrosine phosphorylation,2/42,56/18866,0.00690499664604537,0.0457189866035515,0.0295219425349123,PTPN2/SOCS3,2
GO:0010634,BP,GO:0010634,positive regulation of epithelial cell migration,3/42,176/18866,0.00701650126750567,0.0462535149344782,0.0298671014249318,HBEGF/JUN/RHOB,3
GO:0072431,BP,GO:0072431,signal transduction involved in mitotic G1 DNA damage checkpoint,2/42,57/18866,0.00714604751356377,0.0466978670125494,0.0301540311556329,BTG2/PLK3,2
GO:1902400,BP,GO:1902400,intracellular signal transduction involved in G1 DNA damage checkpoint,2/42,57/18866,0.00714604751356377,0.0466978670125494,0.0301540311556329,BTG2/PLK3,2
GO:0045619,BP,GO:0045619,regulation of lymphocyte differentiation,3/42,181/18866,0.00757693990679166,0.0484478423568121,0.0312840358952136,EGR3/PTPN2/ZFP36L2,3
GO:0031663,BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,2/42,59/18866,0.00763948013211209,0.0484478423568121,0.0312840358952136,CD55/TRIB1,2
GO:0043525,BP,GO:0043525,positive regulation of neuron apoptotic process,2/42,59/18866,0.00763948013211209,0.0484478423568121,0.0312840358952136,JUN/MCL1,2
GO:0071385,BP,GO:0071385,cellular response to glucocorticoid stimulus,2/42,59/18866,0.00763948013211209,0.0484478423568121,0.0312840358952136,ZFP36/ZFP36L2,2
GO:0072413,BP,GO:0072413,signal transduction involved in mitotic cell cycle checkpoint,2/42,59/18866,0.00763948013211209,0.0484478423568121,0.0312840358952136,BTG2/PLK3,2
GO:1902402,BP,GO:1902402,signal transduction involved in mitotic DNA damage checkpoint,2/42,59/18866,0.00763948013211209,0.0484478423568121,0.0312840358952136,BTG2/PLK3,2
GO:1902403,BP,GO:1902403,signal transduction involved in mitotic DNA integrity checkpoint,2/42,59/18866,0.00763948013211209,0.0484478423568121,0.0312840358952136,BTG2/PLK3,2
GO:0043433,BP,GO:0043433,negative regulation of DNA-binding transcription factor activity,3/42,183/18866,0.00780834070167204,0.049104335040222,0.031707950349886,BHLHE40/SIK1/TRIB1,3
GO:2001235,BP,GO:2001235,positive regulation of apoptotic signaling pathway,3/42,183/18866,0.00780834070167204,0.049104335040222,0.031707950349886,ATF3/MCL1/PTPN2,3
GO:0001836,BP,GO:0001836,release of cytochrome c from mitochondria,2/42,60/18866,0.00789182752336969,0.0492679653778014,0.0318136107282508,JUN/LMNA,2
GO:0001936,BP,GO:0001936,regulation of endothelial cell proliferation,3/42,184/18866,0.00792559835369215,0.0492679653778014,0.0318136107282508,EGR3/JUN/NR4A1,3
GO:0002237,BP,GO:0002237,response to molecule of bacterial origin,4/42,356/18866,0.00793269968158879,0.0492679653778014,0.0318136107282508,CD55/FOS/TRIB1/ZFP36,4
GO:0005667,CC,GO:0005667,transcription regulator complex,7/42,413/19559,2.53527824102965e-05,0.0022056920696958,0.00205490973220298,FOS/JUN/JUNB/JUND/NR4A1/NR4A2/NR4A3,7
GO:0090575,CC,GO:0090575,RNA polymerase II transcription regulator complex,4/42,161/19559,0.00038798120829138,0.016877182560675,0.015723448967598,FOS/JUN/JUNB/JUND,4
GO:0140297,MF,GO:0140297,DNA-binding transcription factor binding,9/42,347/18352,7.16611728839517e-08,9.52477837541674e-06,6.44011138714309e-06,BHLHE40/EGR2/FOS/JUN/JUND/NR4A1/NR4A2/NR4A3/SIK1,9
GO:0061629,MF,GO:0061629,RNA polymerase II-specific DNA-binding transcription factor binding,8/42,267/18352,1.39047859495135e-07,9.52477837541674e-06,6.44011138714309e-06,BHLHE40/EGR2/FOS/JUN/JUND/NR4A1/NR4A2/NR4A3,8
GO:0001102,MF,GO:0001102,RNA polymerase II activating transcription factor binding,4/42,47/18352,3.93481816208591e-06,0.000170401925403813,0.000115216054057131,BHLHE40/EGR2/FOS/JUN,4
GO:0035259,MF,GO:0035259,glucocorticoid receptor binding,3/42,15/18352,4.97523869792155e-06,0.000170401925403813,0.000115216054057131,NR4A1/NR4A2/NR4A3,3
GO:0033613,MF,GO:0033613,activating transcription factor binding,4/42,80/18352,3.30351109287078e-05,0.000905162039446593,0.000612018897205533,BHLHE40/EGR2/FOS/JUN,4
GO:0016922,MF,GO:0016922,nuclear receptor binding,4/42,101/18352,8.23693448907457e-05,0.00188076670833869,0.00127166707901502,JUND/NR4A1/NR4A2/NR4A3,4
GO:0004879,MF,GO:0004879,nuclear receptor activity,3/42,52/18352,0.000227828559890596,0.00390156408812646,0.00263801490399638,NR4A1/NR4A2/NR4A3,3
GO:0098531,MF,GO:0098531,ligand-activated transcription factor activity,3/42,52/18352,0.000227828559890596,0.00390156408812646,0.00263801490399638,NR4A1/NR4A2/NR4A3,3
GO:0035257,MF,GO:0035257,nuclear hormone receptor binding,4/42,144/18352,0.000322787690643535,0.00491354595757381,0.00332225927212059,JUND/NR4A1/NR4A2/NR4A3,4
GO:0035497,MF,GO:0035497,cAMP response element binding,2/42,14/18352,0.000457254790616154,0.00626439063144132,0.00423562332360227,JUN/NR4A3,2
GO:0071837,MF,GO:0071837,HMG box domain binding,2/42,16/18352,0.000601225209178434,0.0074879866961314,0.00506294912992365,EGR2/JUN,2
GO:0051427,MF,GO:0051427,hormone receptor binding,4/42,177/18352,0.000703263124930939,0.00802892067629489,0.00542869780648444,JUND/NR4A1/NR4A2/NR4A3,4
GO:0046982,MF,GO:0046982,protein heterodimerization activity,5/42,321/18352,0.00079401091158272,0.00821955537019492,0.00555759410355093,ATF3/BHLHE40/MCL1/NR4A1/NR4A2,5
GO:0035258,MF,GO:0035258,steroid hormone receptor binding,3/42,81/18352,0.000839954563377583,0.00821955537019492,0.00555759410355093,NR4A1/NR4A2/NR4A3,3
GO:0070412,MF,GO:0070412,R-SMAD binding,2/42,23/18352,0.00125477545655911,0.0114602825032399,0.00774878878436504,FOS/JUN,2
GO:0035925,MF,GO:0035925,mRNA 3'-UTR AU-rich region binding,2/42,26/18352,0.00160487058891901,0.013741704417619,0.00929135604111007,ZFP36/ZFP36L2,2
GO:0017091,MF,GO:0017091,AU-rich element binding,2/42,27/18352,0.00173075000720096,0.0139478088815607,0.00943071211354085,ZFP36/ZFP36L2,2
GO:0035035,MF,GO:0035035,histone acetyltransferase binding,2/42,28/18352,0.00186118560255978,0.0141656904194828,0.00957803117106787,EGR1/NR4A3,2
GO:0071889,MF,GO:0071889,14-3-3 protein binding,2/42,32/18352,0.00242808061699657,0.0175077391857121,0.0118377337559944,SIK1/ZFP36,2
GO:0001221,MF,GO:0001221,transcription cofactor binding,2/42,51/18352,0.00607237119037903,0.0415957426540964,0.028124666565966,NR4A3/PER2,2
GO:0001227,MF,GO:0001227,DNA-binding transcription repressor activity, RNA polymerase II-specific,4/42,335/18352,0.00707056844708259,0.0444877490466811,0.030080076189842,ATF3/BHLHE40/BTG2/JUN,4
GO:0001217,MF,GO:0001217,DNA-binding transcription repressor activity,4/42,336/18352,0.00714401809508747,0.0444877490466811,0.030080076189842,ATF3/BHLHE40/BTG2/JUN,4
